STEVANATO GROUP SPA (STVN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:STVN - IT0005452658 - Common Stock
21.3 USD
+0.48 (+2.31%)
We assign a fundamental rating of 5 out of 10 to STVN. STVN was compared to 57 industry peers in the Life Sciences Tools & Services industry. STVN scores excellent on profitability, but there are some minor concerns on its financial health. While showing a medium growth rate, STVN is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
STVN had positive earnings in the past year.
STVN had a positive operating cash flow in the past year.
Each year in the past 5 years STVN has been profitable.
In the past 5 years STVN always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of STVN (5.71%) is better than 80.70% of its industry peers.
STVN has a Return On Equity of 9.60%. This is in the better half of the industry: STVN outperforms 78.95% of its industry peers.
STVN's Return On Invested Capital of 7.91% is amongst the best of the industry. STVN outperforms 80.70% of its industry peers.
The Average Return On Invested Capital over the past 3 years for STVN is below the industry average of 13.99%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.71% | ||
| ROE | 9.6% | ||
| ROIC | 7.91% |
ROA(3y)6.9%
ROA(5y)7.65%
ROE(3y)11.86%
ROE(5y)15.36%
ROIC(3y)9.71%
ROIC(5y)10.46%
1.3 Margins
STVN's Profit Margin of 11.72% is amongst the best of the industry. STVN outperforms 80.70% of its industry peers.
STVN's Profit Margin has improved in the last couple of years.
STVN has a better Operating Margin (17.18%) than 80.70% of its industry peers.
In the last couple of years the Operating Margin of STVN has grown nicely.
STVN's Gross Margin of 28.83% is on the low side compared to the rest of the industry. STVN is outperformed by 73.68% of its industry peers.
In the last couple of years the Gross Margin of STVN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.18% | ||
| PM (TTM) | 11.72% | ||
| GM | 28.83% |
OM growth 3Y-5.27%
OM growth 5Y7.16%
PM growth 3Y-12.48%
PM growth 5Y7.86%
GM growth 3Y-3.05%
GM growth 5Y2.24%
2. Health
2.1 Basic Checks
STVN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
STVN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, STVN has less shares outstanding
Compared to 1 year ago, STVN has an improved debt to assets ratio.
2.2 Solvency
STVN has an Altman-Z score of 5.23. This indicates that STVN is financially healthy and has little risk of bankruptcy at the moment.
STVN has a Altman-Z score of 5.23. This is amongst the best in the industry. STVN outperforms 82.46% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that STVN is not too dependend on debt financing.
STVN has a Debt to Equity ratio of 0.24. This is comparable to the rest of the industry: STVN outperforms 52.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.23 |
ROIC/WACC0.85
WACC9.31%
2.3 Liquidity
STVN has a Current Ratio of 1.79. This is a normal value and indicates that STVN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.79, STVN is not doing good in the industry: 64.91% of the companies in the same industry are doing better.
STVN has a Quick Ratio of 1.22. This is a normal value and indicates that STVN is financially healthy and should not expect problems in meeting its short term obligations.
STVN has a Quick ratio of 1.22. This is in the lower half of the industry: STVN underperforms 68.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.22 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 14.89% over the past year.
The Earnings Per Share has been growing by 27.29% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 6.98% in the past year.
The Revenue has been growing by 15.53% on average over the past years. This is quite good.
EPS 1Y (TTM)14.89%
EPS 3Y-6.42%
EPS 5Y27.29%
EPS Q2Q%16.67%
Revenue 1Y (TTM)6.98%
Revenue growth 3Y9.37%
Revenue growth 5Y15.53%
Sales Q2Q%9.12%
3.2 Future
Based on estimates for the next years, STVN will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.33% on average per year.
STVN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.51% yearly.
EPS Next Y11.64%
EPS Next 2Y16.45%
EPS Next 3Y19.57%
EPS Next 5Y18.33%
Revenue Next Year7.07%
Revenue Next 2Y8.29%
Revenue Next 3Y9.1%
Revenue Next 5Y8.51%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 33.81, STVN can be considered very expensive at the moment.
Based on the Price/Earnings ratio, STVN is valued a bit cheaper than 63.16% of the companies in the same industry.
When comparing the Price/Earnings ratio of STVN to the average of the S&P500 Index (26.55), we can say STVN is valued slightly more expensively.
Based on the Price/Forward Earnings ratio of 27.84, the valuation of STVN can be described as expensive.
70.18% of the companies in the same industry are more expensive than STVN, based on the Price/Forward Earnings ratio.
STVN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.78, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.81 | ||
| Fwd PE | 27.84 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, STVN is valued a bit cheaper than 78.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 21.01 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
STVN has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as STVN's earnings are expected to grow with 19.57% in the coming years.
PEG (NY)2.9
PEG (5Y)1.24
EPS Next 2Y16.45%
EPS Next 3Y19.57%
5. Dividend
5.1 Amount
STVN has a yearly dividend return of 0.28%, which is pretty low.
In the last 3 months the price of STVN has falen by -20.52%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
STVN's Dividend Yield is rather good when compared to the industry average which is at 0.09. STVN pays more dividend than 84.21% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 1.87, STVN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.28% |
5.2 History
STVN has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
10.77% of the earnings are spent on dividend by STVN. This is a low number and sustainable payout ratio.
DP10.77%
EPS Next 2Y16.45%
EPS Next 3Y19.57%
NYSE:STVN (12/15/2025, 8:04:00 PM)
21.3
+0.48 (+2.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners109.54%
Inst Owner Change1.69%
Ins Owners1.61%
Ins Owner ChangeN/A
Market Cap6.45B
Revenue(TTM)1.17B
Net Income(TTM)134.22M
Analysts83.53
Price Target29.57 (38.83%)
Short Float %4.51%
Short Ratio7.01
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.28% |
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP10.77%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.49%
Min EPS beat(2)2.71%
Max EPS beat(2)10.28%
EPS beat(4)3
Avg EPS beat(4)1.61%
Min EPS beat(4)-7.68%
Max EPS beat(4)10.28%
EPS beat(8)3
Avg EPS beat(8)-5.73%
EPS beat(12)6
Avg EPS beat(12)-2.97%
EPS beat(16)10
Avg EPS beat(16)0.11%
Revenue beat(2)2
Avg Revenue beat(2)2.02%
Min Revenue beat(2)1.72%
Max Revenue beat(2)2.33%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)2.33%
Revenue beat(8)3
Avg Revenue beat(8)-0.93%
Revenue beat(12)4
Avg Revenue beat(12)-0.39%
Revenue beat(16)7
Avg Revenue beat(16)-0.02%
PT rev (1m)-0.38%
PT rev (3m)-0.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.35%
EPS NY rev (1m)0.1%
EPS NY rev (3m)0.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.81 | ||
| Fwd PE | 27.84 | ||
| P/S | 4.79 | ||
| P/FCF | N/A | ||
| P/OCF | 26.58 | ||
| P/B | 3.93 | ||
| P/tB | 4.18 | ||
| EV/EBITDA | 21.01 |
EPS(TTM)0.63
EY2.96%
EPS(NY)0.77
Fwd EY3.59%
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)0.8
OCFY3.76%
SpS4.44
BVpS5.42
TBVpS5.1
PEG (NY)2.9
PEG (5Y)1.24
Graham Number8.77
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.71% | ||
| ROE | 9.6% | ||
| ROCE | 10.52% | ||
| ROIC | 7.91% | ||
| ROICexc | 8.33% | ||
| ROICexgc | 8.74% | ||
| OM | 17.18% | ||
| PM (TTM) | 11.72% | ||
| GM | 28.83% | ||
| FCFM | N/A |
ROA(3y)6.9%
ROA(5y)7.65%
ROE(3y)11.86%
ROE(5y)15.36%
ROIC(3y)9.71%
ROIC(5y)10.46%
ROICexc(3y)11.09%
ROICexc(5y)13.59%
ROICexgc(3y)11.88%
ROICexgc(5y)15.21%
ROCE(3y)13.31%
ROCE(5y)14.16%
ROICexgc growth 3Y-28.59%
ROICexgc growth 5Y-6.94%
ROICexc growth 3Y-26.56%
ROICexc growth 5Y-4.42%
OM growth 3Y-5.27%
OM growth 5Y7.16%
PM growth 3Y-12.48%
PM growth 5Y7.86%
GM growth 3Y-3.05%
GM growth 5Y2.24%
F-Score5
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.24 | ||
| Cap/Depr | 338.93% | ||
| Cap/Sales | 23.63% | ||
| Interest Coverage | 22.84 | ||
| Cash Conversion | 74.68% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.22 | ||
| Altman-Z | 5.23 |
F-Score5
WACC9.31%
ROIC/WACC0.85
Cap/Depr(3y)442.35%
Cap/Depr(5y)341.04%
Cap/Sales(3y)31.28%
Cap/Sales(5y)24.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.89%
EPS 3Y-6.42%
EPS 5Y27.29%
EPS Q2Q%16.67%
EPS Next Y11.64%
EPS Next 2Y16.45%
EPS Next 3Y19.57%
EPS Next 5Y18.33%
Revenue 1Y (TTM)6.98%
Revenue growth 3Y9.37%
Revenue growth 5Y15.53%
Sales Q2Q%9.12%
Revenue Next Year7.07%
Revenue Next 2Y8.29%
Revenue Next 3Y9.1%
Revenue Next 5Y8.51%
EBIT growth 1Y6.22%
EBIT growth 3Y3.61%
EBIT growth 5Y23.8%
EBIT Next Year69.85%
EBIT Next 3Y33.48%
EBIT Next 5Y24.61%
FCF growth 1Y70.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.91%
OCF growth 3Y5.33%
OCF growth 5Y29.6%
STEVANATO GROUP SPA / STVN FAQ
What is the ChartMill fundamental rating of STEVANATO GROUP SPA (STVN) stock?
ChartMill assigns a fundamental rating of 5 / 10 to STVN.
Can you provide the valuation status for STEVANATO GROUP SPA?
ChartMill assigns a valuation rating of 3 / 10 to STEVANATO GROUP SPA (STVN). This can be considered as Overvalued.
How profitable is STEVANATO GROUP SPA (STVN) stock?
STEVANATO GROUP SPA (STVN) has a profitability rating of 7 / 10.
What are the PE and PB ratios of STEVANATO GROUP SPA (STVN) stock?
The Price/Earnings (PE) ratio for STEVANATO GROUP SPA (STVN) is 33.81 and the Price/Book (PB) ratio is 3.93.
What is the earnings growth outlook for STEVANATO GROUP SPA?
The Earnings per Share (EPS) of STEVANATO GROUP SPA (STVN) is expected to grow by 11.64% in the next year.